BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24860631)

  • 1. What's new in renal cell cancer research? Highlights of GU-ASCO 2014.
    Kapoor A
    Can Urol Assoc J; 2014 Mar; 8(3-4 Suppl 2):S13-5. PubMed ID: 24860631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What's new in prostate cancer research? Highlights of GU-ASCO 2014.
    Kapoor A
    Can Urol Assoc J; 2014 Mar; 8(3-4 Suppl 2):S8-S12. PubMed ID: 24860635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian content at GU-ASCO 2014: Highlights of research involving Canadian researchers.
    Kapoor A
    Can Urol Assoc J; 2014 Mar; 8(3-4 Suppl 2):S16-8. PubMed ID: 24860632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What's New in Renal Cell Cancer Research? Highlights of GU-ASCO 2015.
    Kapoor A
    Can Urol Assoc J; 2015; 9(5-6Suppl3):S154-5. PubMed ID: 26221195
    [No Abstract]   [Full Text] [Related]  

  • 5. Inside the 2015 ASCO Genitourinary Cancers Symposium.
    Santoni M; Massari F; Iacovelli R; Ciccarese C; Verri E; Burattini L; Montironi R; Nolè F; Tortora G; Cascinu S
    Future Oncol; 2015; 11(13):1859-62. PubMed ID: 26161923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's New in Prostate Cancer Research? Highlights of GU-ASCO 2015.
    Kapoor A
    Can Urol Assoc J; 2015; 9(5-6Suppl3):S148-53. PubMed ID: 26221194
    [No Abstract]   [Full Text] [Related]  

  • 7. [What's new in 2009 about urothelial tumors? Live from EAU, AUA and ASCO, ASCO-GU].
    Amsellem-Ouazana D; Theodore C; Irani J; Bernardini S; Bonnal JL; Chauvet B; Colombel M; Davin JL; Laurent G; Lebret T; Maidenberg M; Mazerolles C; Pfister C; Roupret M; Roy C; Rozet F; Saint F; Soulié M; Guillotreau J
    Prog Urol; 2010 Mar; 20 Suppl 1():S38-40. PubMed ID: 20493442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2023 American Society of Clinical Oncology Genitourinary (ASCO-GU) Cancers Symposium Meeting highlights.
    Aprikian A; Blais N; Breau RH; Kollmannsberger C; Niazi T; Fleshner NE; Gray S
    Can Urol Assoc J; 2023 May; 17(5):E144-E151. PubMed ID: 37185211
    [No Abstract]   [Full Text] [Related]  

  • 9. 2024 American Society of Clinical Oncology Genitourinary (ASCO-GU) Cancers Symposium Meeting highlights.
    Graham J; Fallah-Rad N; Kolinsky M; Morgan S; Shayegan B
    Can Urol Assoc J; 2024 May; 18(5):E179-E186. PubMed ID: 38838354
    [No Abstract]   [Full Text] [Related]  

  • 10. Highlights from the ASCO Genitourinary Symposium 2014: focus on renal and prostate cancer.
    Iacovelli R; Santoni M; de Braud F; Cascinu S; Procopio G
    Expert Rev Anticancer Ther; 2014 Dec; 14(12):1407-9. PubMed ID: 25159199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 - kidney cancer.
    Buti S; Ciccarese C; Iacovelli R; Bersanelli M; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R; Tortora G; Massari F
    Future Oncol; 2016 Sep; 12(17):1967-70. PubMed ID: 27312426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New treatments and trials for renal cell carcinoma: Latest updates from 2023 ASCO-GU Cancers Symposium.
    Guo Y; Wu R; Ye L; Wang L
    Asian J Surg; 2023 Nov; 46(11):5136-5138. PubMed ID: 37453863
    [No Abstract]   [Full Text] [Related]  

  • 13. Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer.
    Buti S; Ciccarese C; Iacovelli R; Bersanelli M; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R; Tortora G; Massari F
    Future Oncol; 2016 Sep; 12(17):1971-4. PubMed ID: 27312584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
    Lin SY; Linehan JA; Wilson TG; Hoon DSB
    Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlights in Advanced Prostate Cancer from the 2019 ASCO Genitourinary Cancers Symposium: Commentary.
    George DJ
    Clin Adv Hematol Oncol; 2019 Apr; 17 Suppl 8(4):17-19. PubMed ID: 32692735
    [No Abstract]   [Full Text] [Related]  

  • 16. Highlights in Advanced Prostate Cancer From the 2019 ASCO Genitourinary Cancers Symposium.
    Clin Adv Hematol Oncol; 2019 Apr; 17 Suppl 8(4):1-19. PubMed ID: 32692734
    [No Abstract]   [Full Text] [Related]  

  • 17. 2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Genitourinary (Non-Prostate) Cancers.
    J Adv Pract Oncol; 2019 Aug; 10(6):554-559. PubMed ID: 33364066
    [No Abstract]   [Full Text] [Related]  

  • 18. Scientific Advancements in Drug Development and Trials for Urothelial Carcinoma: Insights From the 2023 ASCO-GU Cancers Symposium.
    Feng D; Li D; Wu R; Han P
    Aging Dis; 2023 Dec; 14(6):1953-1957. PubMed ID: 37199595
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmaceutical treatment of advanced urinary bladder cancer: new developments in 2014].
    Schmid SC; Gschwend JE; Retz M
    Urologe A; 2014 Oct; 53(10):1535-42. PubMed ID: 25234951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium: Meeting highlights.
    Kapoor A; Niazi T; Noonan K; Rendon RA; Alimohamed N; Kassouf W; Berlin A; Chu W; Kollmannsberger C; So AI
    Can Urol Assoc J; 2022 Apr; 16(4):125-131. PubMed ID: 35358413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.